Foghorn Therapeutics Statistics
Total Valuation
FHTX has a market cap or net worth of $117.58 million. The enterprise value is $5.23 million.
| Market Cap | 117.58M |
| Enterprise Value | 5.23M |
Important Dates
The next confirmed earnings date is Monday, November 9, 2026, before market open.
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
FHTX has 59.39 million shares outstanding. The number of shares has increased by 10.35% in one year.
| Current Share Class | 59.39M |
| Shares Outstanding | 59.39M |
| Shares Change (YoY) | +10.35% |
| Shares Change (QoQ) | +2.78% |
| Owned by Insiders (%) | 7.40% |
| Owned by Institutions (%) | 37.56% |
| Float | 25.58M |
Valuation Ratios
The trailing PE ratio is 14.67.
| PE Ratio | 14.67 |
| Forward PE | n/a |
| PS Ratio | 1.07 |
| Forward PS | 6.78 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.81 |
| EV / Sales | 0.07 |
| EV / EBITDA | 0.73 |
| EV / EBIT | 0.85 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.24
| Current Ratio | 4.24 |
| Quick Ratio | 4.19 |
| Debt / Equity | n/a |
| Debt / EBITDA | 3.49 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 2.82% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 5.82% |
| Weighted Average Cost of Capital (WACC) | 16.03% |
| Revenue Per Employee | $1.06M |
| Profits Per Employee | $88,868 |
| Employee Count | 106 |
| Asset Turnover | 0.57 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -53.25% in the last 52 weeks. The beta is 3.21, so FHTX's price volatility has been higher than the market average.
| Beta (5Y) | 3.21 |
| 52-Week Price Change | -53.25% |
| 50-Day Moving Average | 3.13 |
| 200-Day Moving Average | 4.61 |
| Relative Strength Index (RSI) | 26.03 |
| Average Volume (20 Days) | 662,793 |
Short Selling Information
The latest short interest is 2.46 million, so 4.13% of the outstanding shares have been sold short.
| Short Interest | 2.46M |
| Short Previous Month | 2.15M |
| Short % of Shares Out | 4.13% |
| Short % of Float | 9.60% |
| Short Ratio (days to cover) | 1.91 |
Income Statement
In the last 12 months, FHTX had revenue of $112.13 million and earned $9.42 million in profits. Earnings per share was $0.13.
| Revenue | 112.13M |
| Gross Profit | 26.66M |
| Operating Income | 8.94M |
| Pretax Income | 9.42M |
| Net Income | 9.42M |
| EBITDA | 10.42M |
| EBIT | 8.94M |
| Earnings Per Share (EPS) | $0.13 |
Balance Sheet
The company has $156.22 million in cash and $43.87 million in debt, with a net cash position of $112.35 million or $1.89 per share.
| Cash & Cash Equivalents | 156.22M |
| Total Debt | 43.87M |
| Net Cash | 112.35M |
| Net Cash Per Share | $1.89 |
| Equity (Book Value) | -14.08M |
| Book Value Per Share | -0.23 |
| Working Capital | 121.00M |
Cash Flow
In the last 12 months, operating cash flow was -$83.62 million and capital expenditures -$57,000, giving a free cash flow of -$83.68 million.
| Operating Cash Flow | -83.62M |
| Capital Expenditures | -57,000 |
| Depreciation & Amortization | 1.49M |
| Net Borrowing | n/a |
| Free Cash Flow | -83.68M |
| FCF Per Share | -$1.41 |
Margins
Gross margin is 23.78%, with operating and profit margins of 7.97% and 8.40%.
| Gross Margin | 23.78% |
| Operating Margin | 7.97% |
| Pretax Margin | 8.40% |
| Profit Margin | 8.40% |
| EBITDA Margin | 9.29% |
| EBIT Margin | 7.97% |
| FCF Margin | n/a |
Dividends & Yields
FHTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -10.35% |
| Shareholder Yield | -10.35% |
| Earnings Yield | 6.82% |
| FCF Yield | -69.76% |
Analyst Forecast
The average price target for FHTX is $4.17, which is 110.46% higher than the current price. The consensus rating is "Buy".
| Price Target | $4.17 |
| Price Target Difference | 110.46% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (3Y) | -38.67% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |